⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 15, 2024

[Efficacy and safety of dust mite subcutaneous immunotherapy in children with allergic asthma： a prospective randomized controlled study].

Yani Wang Siqi Lu Hai Chen Yuqin Li Hongyan Lu Hui Zhu Ming‐Fu Chang

View at Publisher

Ask AI

Bookmark

Share

Abstract

To investigate the efficacy and safety of subcutaneous immunotherapy (SCIT) using dust mites in children with allergic asthma.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wang et al. (2024) studied this question.

synapsesocial.com/papers/68e649f5b6db6435875da85e https://doi.org/10.7499/j.issn.1008-8830.2309137

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Subcutaneous Allergen Immunotherapy in Adults Allergic to House Dust Mites: A Phase 3 Randomized Controlled Trial2025 · 6 citations
2Evaluation and Comparison of the Efficacy of Subcutaneous and Sublingual Immunotherapy for the Treatment of Allergic Asthma in Children2024 · 2 citations
3Efficacy and safety of subcutaneous immunotherapy combined with omalizumab in children with dust mite-induced asthma2024 · 2 citations
4The safety and tolerability of a one strength dose-escalation scheme for subcutaneous immunotherapy with a native house dust mite extract in Chinese children: A multicenter, randomized, open label clinical trial2024 · 5 citations
5[Efficacy and safety study of standardized mite allergen specific immunotherapy with no reduction during maintenance in children with respiratory allergic disease].2024

More related papers

Safety and Effectiveness of Subcutaneous Immunotherapy with a Glutaraldehyde-Polymerized Mite Allergen Extract in Adults and Children with Allergic Rhinitis with or Without Asthma Due to Dermatophagoides2026
Persistence and Reasons for Discontinuation of Subcutaneous Immunotherapy in Children with Dust Mite Allergy: A Real-World Cohort from Hangzhou, China2026
Effectiveness of allergen immunotherapy with house dust mite extract for pediatric bronchial asthma2024